Syed Mumtaz, MD
Child & Adolescent Psychiatry · Fort Wayne, INNPI 1396718573
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 43 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 12 manufacturers reported payments, led by Sunovion Pharmaceuticals Inc. at 51.7% of the total. Reporting peaked in 2020 at $235 and has fallen 83.2% since, to $40 in 2024.
Across 43 payments — averaging $15.02 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Sunovion Pharmaceuticals Inc.$334
- Ironshore Pharmaceuticals Inc.$84
- AbbVie$57
- Johnson & Johnson$43
- Alkermes, Inc.$25
- Otsuka America Pharmaceutical, Inc.$19
- plus $84 from 6 others
What the payments were for
- Food & beverage$646100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Sunovion Pharmaceuticals Inc. | 23 | $334 |
| Ironshore Pharmaceuticals Inc. | 5 | $84 |
| AbbVie(2 entities) | 3 | $57 |
| Johnson & Johnson | 3 | $43 |
| Alkermes, Inc. | 2 | $25 |
| Otsuka America Pharmaceutical, Inc. | 1 | $19 |
| Almatica Pharma LLC | 1 | $18 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $16 |
| Teva Pharmaceuticals USA, Inc. | 1 | $15 |
| Neurocrine Biosciences, Inc. | 1 | $14 |
| Merck | 1 | $12 |
| Corium, LLC | 1 | $10 |
How this compares
$646 in reported general payments places this provider in the 60th percentile of 56 child & adolescent psychiatry providers in Indiana.
See all child & adolescent psychiatry providers in Indiana →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| RexultiBrexpiprazole | 24 | $34,239 |
| Olanzapine OdtOlanzapine | 12 | $4,543 |
| Aripiprazole | 29 | $2,266 |
| Vilazodone Hcl | 33 | $1,965 |
| Desvenlafaxine Succinate ErDesvenlafaxine Succinate | 22 | $1,682 |
| Buspirone Hcl | 82 | $1,228 |
| Venlafaxine Hcl ErVenlafaxine Hcl | 106 | $1,164 |
| Hydroxyzine Hcl | 41 | $996 |
| Bupropion XlBupropion Hcl | 49 | $889 |
| Trazodone Hcl | 97 | $829 |
| Quetiapine Fumarate | 39 | $720 |
| Clonazepam | 55 | $446 |
| Oxcarbazepine | 14 | $420 |
| Fluoxetine Hcl | 21 | $412 |
| Prazosin Hcl | 19 | $292 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Otsuka America Pharmaceutical, Inc.Rexulti | $19 | $34,23924 claims |
| Almatica Pharma LLCSertraline Hcl | $18 | $22268 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 56 child & adolescent psychiatry providers in Indiana.
Other child & adolescent psychiatry in Fort Wayne
- Elizabeth PfeifferFort Wayne$1K
- Ambreen GhoriFort Wayne$922
- Sharon CurtisDyer$102K
- Christopher McDougleIndianapolis$17K
- Ann KledzikIndianapolis$12K
- Teresita Briones RamiloIndianapolis$7K
- Mitchell GoldsteinSouth Bend$6K
- Lia KettenisBloomington$6K
- Hugh StarksIndianapolis$4K
- Daniel KinseyGoshen$3K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.